NCT02695771View on ClinicalTrials.gov

The Bladder Instillation Comparison Study

PHASE3CompletedINTERVENTIONAL
Enrollment

101

Participants

Timeline

Start Date

April 19, 2016

Primary Completion Date

October 22, 2021

Study Completion Date

October 22, 2021

Conditions
Urinary Bladder Neoplasms
Interventions
DRUG

Mitomycin C

Cancer chemotherapeutic agent

DRUG

Gemcitabine

Cancer chemotherapeutic agent

Trial Locations (3)

49503

Spectrum Health Medical Group-Division of Urology-LHCP, Grand Rapids

Spectrum Health Medical Group-Division of Urology, Grand Rapids

Urologic Consultants P.C., Grand Rapids

All Listed Sponsors
lead

Spectrum Health Hospitals

OTHER

NCT02695771 - The Bladder Instillation Comparison Study | Biotech Hunter | Biotech Hunter